Latest Licensing News

Aurum Resources has locked in a $35.6 million private placement led by strategic investors including the Lundin Family, Montage Gold, and Zhaojin Mining to accelerate drilling and development at its key gold projects in Côte d’Ivoire.

DMC Mining Limited has extended the closing date for its public share offer to August 2025 due to delays in securing exploration licences for its key Guinea projects. The company plans further regulatory updates to accommodate these changes.

Terra Metals has exercised its option to acquire HRM Exploration, significantly expanding its Dante Project tenure in Western Australia’s West Musgrave region. The all-scrip deal positions Terra to accelerate exploration in a mineral-rich province analogous to South Africa’s Bushveld.

TMK Energy reports significant progress in reducing reservoir pressure at its Gurvantes XXXV Coal Seam Gas Pilot Well, approaching the critical threshold for enhanced gas production.

Aguia Resources reports steady underground mining at 15 tonnes per day at its Santa Barbara Gold Project, with plans to boost processing capacity to 50 tonnes per day by July 2025 and imminent gold sales.

A landmark High Court ruling in South Africa exempts upstream petroleum activities from the Gas Act, easing regulatory burdens for companies like Renergen and Tetra4.

Brightstar Resources outlines an ambitious growth plan targeting over 200,000 ounces of gold production annually by 2029, driven by expansions at Laverton and Menzies hubs and accelerated development of the Sandstone project.

Larvotto Resources has released a definitive feasibility study for its Hillgrove Antimony-Gold Project, confirming robust economics and a targeted production start in 2026. The study outlines an 8-year mine life with strong margins and advanced project financing talks.

Global Uranium and Enrichment Limited has completed a scoping study for its Hansen Deposit in Colorado, revealing strong economic potential through innovative mining and beneficiation methods.

Silex Systems reports steady progress on its TRL-6 uranium enrichment demonstration, targeting completion by end-2025, while securing initial US government funding to support commercialisation efforts.

Wellnex Life Limited announces key board and management changes following its successful AIM Market dual listing, including the resignation of its Non-Executive Chairman and appointment of a joint CEO to drive growth.

Dimerix has received a US$30 million upfront payment from Amicus Therapeutics for exclusive US rights to DMX-200, a promising kidney disease therapy. The deal positions Dimerix for up to US$560 million in further milestones plus royalties, underpinning its global licensing strategy.